NovioSense BV is a spin out company from Fraunhofer Gesellschaft and NovioTech BV based in Nijmegen. NovioSense is a wireless platform technology for non-invasive monitoring of disease biomarkers. The first sensor based on the NovioSense technology is a wireless non-invasive glucose sensor. Development is targeted at a clinical prototype for non-invasive continuous monitoring of glucose levels in tear fluid.
Location: Netherlands, Gelderland, Nijmegen
Employees: 11-50
Founded date: 2012
Investors 1
| Date | Name | Website |
| - | Oost NL | oostnl.com |
Mentions in press and media 2
| Date | Title | Description |
| 13.07.2023 | Startup Showcase: NOVIOSENSE Revolutionizes Non-Invasive Glucose Monitoring | Welcome to the Startup Showcase, where we bring you the latest groundbreaking ventures that are shaping industries and changing lives. In this edition, we introduce NOVIOSENSE, a Dutch startup based in Nijmegen that is on a mission to revol... |
| 25.10.2018 | NovioSense Announces Positive Phase 2 Clinical Trial Results and the Commencement of a Second Follow Up Study | NovioSense has demonstrated the measurement of tear glucose in diabetic patients and the correlation to blood glucose with clinically relevant accuracy. The company announced the commencement of a second, 24-patient study, to validate the u... |